Stock price when the opinion was issued
Has been very negative on this name. Thematically they have incurred a ton of debt to develop oil sands and when you are the marginal cost barrel in the oil sands and financing it with debt, it is a risky business and it didn’t work out for them. Have gone through a process of management change, selling assets, etc. Still have a lot of challenges ahead.
Made a big splash into the US by buying a radiology business, which didn’t work out well. Have a new CEO with a new focus. In a few months we’ll hear from the Ontario Ministry of Health with what their sentiment will be on their labs. Dividend had already been cut. He is sticking with it. 7.2% dividend yield.